Treatment of Refractory Pityriasis Rubra Pilaris With Novel Phosphodiesterase 4 (PDE4) Inhibitor Apremilast.

Autor: Krase IZ; University of Arizona College of Medicine, Tucson., Cavanaugh K; Department of Dermatology, University of Arizona, Tucson., Curiel-Lewandrowski C; Department of Dermatology, University of Arizona, Tucson.
Jazyk: angličtina
Zdroj: JAMA dermatology [JAMA Dermatol] 2016 Mar; Vol. 152 (3), pp. 348-50.
DOI: 10.1001/jamadermatol.2015.3405
Databáze: MEDLINE